Comprehensive analysis and validation of novel immune and vascular remodeling related genes signature associated with drug interactions in pulmonary arterial hypertension by Jie Wang, Md. Nazim Uddin, Rui Wang, Yue-hong Gong, Yun Wu

Get full text

Potential drug interactions and duplicate prescriptions among ambulatory cancer patients: a prevalence study using an advanced screening method by Schuitenmaker Martin S, Boom Frits A, Swart Eleonora L, van Leeuwen Roelof WF, Hugtenburg Jacqueline G

“…For the first time the prevalence of drug interactions with OTC-drugs in cancer patients will be studied. …”
Get full text

Simulation of pharmacokinetic drug-drug interaction and dosage regimens optimization of nelfinavir and cepharanthine as a potential combination against COVID-19 by Wichit Nosoongnoen

“…The pharmacokinetic (PK) drug-drug interactions (DDIs) of nelfinavir and cepharanthine combination is limited information in human. …”
Get full text

The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions by K. Sandy Pang, H. Benson Peng, Keumhan Noh

Subjects: Get full text

Signal Detection in Pharmacovigilance: A Review of Informatics-driven Approaches for the Discovery of Drug-Drug Interaction Signals in Different Data Sources by Heba Ibrahim, A. Abdo, Ahmed M. El Kerdawy, A. Sharaf Eldin

Subjects: Get full text

The Impact of Drug–Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma by Silvia Mezi, Andrea Botticelli, Simone Scagnoli, Giulia Pomati, Giulia Fiscon, Federica De Galitiis, Francesca Romana Di Pietro, Sofia Verkhovskaia, Sasan Amirhassankhani, Simona Pisegna, Giovanna Gentile, Maurizio Simmaco, Bjoern Gohlke, Robert Preissner, Paolo Marchetti

Subjects: Get full text

Prescription analysis and evaluation of potential drug–drug interactions among patients attending the geriatric unit at a tertiary care hospital by Harsh Joshi, Falguni D Majumdar, Shreya N Patel, Krishna Bhavin Modi, Jaydeep Rathod, Parth Kanani, Karan B Shah, Supriya Deepak Malhotra

Subjects: Get full text

Pharmacokinetic Herb-Drug Interactions of Glipizide with Andrographis paniculata (Burm. f.) and Andrographolide in Normal and Diabetic Rats by Validated HPLC Method by Sundhani, Elza, Nugroho, Agung Endro, Nurrochmad, Arief, Puspitasari, Ika, Amalia Prihati, Dita, Lukitaningsih, Endang

“…This study aimed to determine the potential pharmacokinetics of herb–drug interactions between GLZ and APE/AND in the plasma of normal and diabetic rats using the HPLC bioanalysis method. …”
Get full text

An individual participant data population pharmacokinetic meta-analysis of drug-drug interactions between lumefantrine and commonly used antiretroviral treatment by Francis, J, Barnes, KI, Workman, L, Kredo, T, Vestergaard, LS, Hoglund, RM, Byakika-Kibwika, P, Lamorde, M, Walimbwa, SI, Chijioke-Nwauche, I, Sutherland, CJ, Merry, C, Scarsi, KK, Nyagonde, N, Lemnge, MM, Khoo, SH, Bygbjerg, IC, Parikh, S, Aweeka, FT, Tarning, J, Denti, P

“…Treating malaria in HIV-coinfected individuals should consider potential drug-drug interactions. Artemether-lumefantrine is the most widely recommended treatment for uncomplicated malaria globally. …”

Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: a multicentre audit. by Wilcock, A, Thomas, J, Frisby, J, Webster, M, Keeley, V, Finn, G, Fossey, K, Wee, B, Beale, J, Lennard, MS

“… AIM: To determine the potential for drug interactions involving cytochrome P450 (CYP) in patients receiving palliative day care. …”

Potential for drug interactions involving cytochrome P450 in patients attending palliative care day centres: a multicentre survey by Wilcock, A, Thomas, J, Frisby, J, Webster, M, Keeley, V, Finn, G, Fossey, K, Wee, B, Beale, J, Lennard, MS

Antitargets : prediction and prevention of drug side effects / by Vaz, Roy J., Klabunde, Thomas

Subjects:

Are your prescriptions killing you? : how to prevent dangerous interactions, avoid deadly side effects, and be healthier with fewer drugs / by Neel, Armon B., author, Hogan, Bill, 1953- author

Subjects:

Burden of comorbidities and their treatment in patients with active tuberculosis: A prospective study by Venkat Manolasya, D T Katyarmal, T Muni Suneel Babu, T Sreeja Prasad, T Preethi, B Priyanka, G Robin

Subjects: Get full text

Negative effects of rivaroxaban observed in a patient with multiple common risks triggered by a bicycle accident by Kurumi Abe, Kenji Momo, Yuji Oto, Masaki Kida, Takuma Iwakiri, Katsumi Tanaka, Tadanori Sasaki

Subjects: “…drug–drug interaction…”
Get full text

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets by Ghim JL, Phuong NTT, Kim MJ, Kim EJ, Song GS, Ahn S, Shin JG, Kim EY

Subjects: Get full text

Interaction and potential mechanisms between atorvastatin and voriconazole, agents used to treat dyslipidemia and fungal infections by Tianrong Xun, Yan Rong, Bin Lv, Jinfei Tian, Qing Zhang, Xixiao Yang

Subjects: Get full text

Pharmacokinetic Interactions between Canagliflozin and Sorafenib or Lenvatinib in Rats by Yanjun Cui, Ying Li, Caihui Guo, Yajing Li, Yinling Ma, Zhanjun Dong

Subjects: Get full text

How Probiotics Affect the Microbiota by Grégoire Wieërs, Leila Belkhir, Raphaël Enaud, Sophie Leclercq, Jean-Michel Philippart de Foy, Isabelle Dequenne, Philippe de Timary, Patrice D. Cani

Subjects: Get full text

METHOTREXATE AND PROTON PUMP INHIBITORS: ARE THERE ANY NEGATIVE PHARMACOLOGIAL EFFECTS? by Andrey E Karateev, Yu A Ermakova, A N Berezyuk, E S Solov’eva

Subjects: Get full text